Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an announcement.
China Isotope & Radiation Corporation has announced the approval and upcoming launch of its novel Su π one 13C breath analyzer, which has received a Class II medical device registration certificate. This device represents a significant advancement in Helicobacter pylori breath testing technology, offering more reliable and efficient diagnostics. The analyzer reduces testing time from 2 minutes to 30 seconds, enhancing user experience and allowing for broader application in large-scale screening scenarios. This development supports early screening and diagnosis systems for gastric cancer in China, potentially improving healthcare resource utilization.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) is a company based in the People’s Republic of China, specializing in the development and provision of medical devices and technologies. The company focuses on innovations in medical testing, particularly in the field of isotope and radiation technologies.
Average Trading Volume: 425,587
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.32B
For detailed information about 1763 stock, go to TipRanks’ Stock Analysis page.